Post by
SkywalkerofLukeon Aug 05, 2022 3:44pm
AGN.c AGNPF (a clinical stage Canadian pharmaceutical development company) announced Wednesday they’ve been invited to present the results from its Phase 2a Study of NP-120 for idiopathic pulmonary
...more